This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Vanaclocha F, Daudén E, Badía X, Guillén C, Conejo-Mir JS, Sainz de los Terreros M, Hamel L, Llorens MA, HEIS Study Group.Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream. British Journal of Dermatology 156: 769-771, No. 4, Apr 2007
Rights and permissions
About this article
Cite this article
Imiquimod cream is a “cost-effective alternative” to excisional surgery for patients with superficial basal cell carcinoma. Pharmacoecon. Outcomes News 529, 12 (2007). https://doi.org/10.2165/00151234-200705290-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705290-00034